Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccines

Infection and Immunity

Volumn 72, Issue 11, 2004, Pages 6418-6425

  Verch, Thorsten ^a   Pan, Zhen Kun ^a   Paterson, Yvonne ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; CANCER VACCINE; DEXTRO ALANINE; DNA VACCINE; RACEMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ESCHERICHIA COLI; FOOD AND DRUG ADMINISTRATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LISTERIA MONOCYTOGENES; PLASMID; PRIORITY JOURNAL; SHUTTLE VECTOR; TUMOR REGRESSION;

ALANINE RACEMASE; ANIMALS; CANCER VACCINES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FEMALE; GENE DELETION; GENETIC VECTORS; HUMANS; IMMUNIZATION; LISTERIA MONOCYTOGENES; MICE; MICE, INBRED C57BL; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PLASMIDS; T-LYMPHOCYTES, CYTOTOXIC; UTERINE CERVICAL NEOPLASMS; VACCINES, DNA;

EID: 7044260685     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.11.6418-6425.2004     Document Type: Article

References (33)

1. Ausubel, K., R. Brent, and R. E. Kingston. 1997. Current protocols in molecular biology. Wiley Interscience, New York, N.Y.
2. Behnke, D., M. S. Gilmore, and J. J. Ferretti. 1981. Plasmid pGB301, a new multiple resistance streptococcal cloning vehicle and its use in cloning of a gentamicin/kanamycin resistance determinant. Mol. Gen. Genet. 182:414-421.
3. Brantl, S., D. Behnke, and J. C. Alonso. 1990. Molecular analysis of the replication region of the conjugative Streptococcus agalactiae plasmid pIP301 in Bacillus subtilis. Comparison with plasmids pAM beta 1 and pSM19035. Nucleic Acids Res. 18:4783-4790.
4. Bron, P. A., M. G. Benchimol, J. Lambert. E. Palumbo, M. Deghorain, J. Delcour, W. M. De Vos, M. Kleerebezem, and P. Hols. 2002. Use of the air gene as a food-grade selection marker in lactic acid bacteria. Appl. Environ. Microbiol. 68:5663-5670.
5. Burd, E. M. 2003. Human papillomavirus and cervical cancer. Clin. Microbiol. Rev. 16:1-17.
6. Cranenburgh, R. M., J. A. Hanak, S. G. Williams, and D. J. Sherratt. 2001. Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration. Nucleic Acids Res. 29:E26.
7. Dunstan, S. J., C. P. Simmons, and R. A. Strugnell. 2003. In vitro and in vivo stability of recombinant plasmids in a vaccine strain of Salmonella enterica var. Typhimurium. FEMS Immunol. Med. Microbiol. 37:111-119.
8. Fennelly, G. J., S. A. Khan, M. A. Abadi, T. F. Wild, and B. R. Bloom. 1999. Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector. J. Immunol. 162:1603-1610.
9. Food and Drug Administration. 1998. Guidance for human somatic cell therapy and gene therapy. Food and Drug Administration, Washington, D.C.
10. Food and Drug Administration. 1996. Points to consider on plasmid DNA vaccines for preventive infectious disease indications. Food and Drug Administration, Washington, D.C.
11. Galen, J. E., and M. M. Levine. 2001. Can a 'flawless' live vector vaccine strain be engineered? Trends Microbiol. 9:372-376.
12. Galen, J. E., J. Nair, J. Y. Wang, S. S. Wasserman, M. K. Tanner, M. B. Sztein, and M. M. Levine. 1999. Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect. Immun. 67:6424-6433.
13. Gunn, G. R., A. Zubair, C. Peters, Z. K. Pan, T. C. Wu, and Y. Paterson. 2001. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T-cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. J. Immunol. 167:6471-6479.
14. Halbert, C. L., G. W. Deniers, and D. A. Galloway. 1992. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol. 66:2125-2134.
15. Jabbar, I. A., G. J. Fernando, N. Saunders, A. Aldovini, R. Young, K. Malcolm, and I. H. Frazer. 2000. Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 proteins. Vaccine 18:2444-2453.
16. Kanda, T., S. Watanabe, and K. Yoshiike. 1988. Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragments controlled by the SV40 promoter. Virology 165:321-325.
17. Kawahara, M., K. Matsuo, T. Nakasone, T. Hiroi, H. Kiyono, S. Matsumoto, T. Yamada, N. Yamamoto, and M. Honda. 2002. Combined intrarectal/ intradermal inoculation of recombinant Mycobacterium bovis bacillus Calmette-Guerin (BCG) induces enhanced immune responses against the inserted HIV-1 V3 antigen. Vaccine 21:158-166.
18. Kohler, S., A. Buben, M. Vogel, and W. Goebel. 1991. Expression of the iap gene coding for protein p60 of Listeria monocytogenes is controlled on the posttranscriptional level. J. Bacteriol. 173:4668-4674.
19. +-T-cell responses that home to the tumor site. J. Virol. 75:9654-9664.
20. Lauer, P., M. Y. Chow, M. J. Loessner, D. A. Portnoy, and R. Calendar. 2002. Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors. J. Bacteriol. 184:4177-4186.
21. Lemaitre, J. P., H. Echchannaoui, G. Michaut, C. Divies, and A. Rousset. 1998. Plasmid-mediated resistance to antimicrobial agents among listeriae. J. Food Prot. 61:1459-1464.
22. Lin, K. Y., F. G. Guarnieri, K. F. Staveley-O'Carroll, H. I. Levitsky, J. T. August, D. M. Pardoll, and T. C. Wu. 1996. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56:21-26.
23. National Antimicrobial Resistance Monitoring System. 2001. Annual report. Centers for Disease Control, Atlanta, Ga.
24. Park, S. F., and G. S. Stewart. 1990. High-efficiency transformation of Listeria monocytogenes by electroporation of penicillin-treated cells. Gene 94:129-132.
25. Peters, C., and Y. Paterson. 2003. Enhancing the immunogenicity of bio-engineered Listeria monocytogenes by passaging through live animal hosts. Vaccine 21:1187-1194.
26. Pilgrim, S., J. Stritzker, C. Schoen, A. Kolb-Maurer, G. Geginat, M. J. Loessner, I. Gentschev, and W. Goebel. 2003. Bactofection of mammalian cells by Listeria monocytogenes: improvement and mechanism of DNA delivery. Gene Ther. 10:2036-2045.
27. Strych, U., and M. J. Benedik. 2002. Mutant analysis shows that alanine racemases from Pseudomonas aeruginosa and Escherichia coli are dimeric. J. Bacteriol. 184:4321-4325.
28. Strych, U., R. L. Penland, M. Jimenez, K. L. Krause, and M. J. Benedik. 2001. Characterization of the alanine racemases from two mycobacteria. FEMS Microbiol. Lett. 196:93-98.
29. Thompson, R. J., H. G. Bouwer, D. A. Portnoy, and F. R. Frankel. 1998. Pathogenicity and immunogenicity of a Listeria monocylogenes strain that requires D-alanine for growth. Infect. Immun. 66:3552-3561.
30. Wasserman, S. A., C. T. Walsh, and D. Botstein. 1983. Two alanine racemase genes in Salmonella typhimurium that differ in structure and function. J. Bacteriol. 153:1439-1450.
31. Williams, S. G., R. M. Cranenburgh, A. M. Weiss, C. J. Wrighton, D. J. Sherratt, and J. A. Hanak. 1998. Represser titration: a novel system for selection and stable maintenance of recombinant plasmids. Nucleic Acids Res. 26:2120-2124.
32. Wirth, R., F. Y. An, and D. B. Clewell. 1986. Highly efficient protoplast transformation system for Streptococcus faecalis and a new Escherichia coli-S. faecalis shuttle vector. J. Bacteriol. 165:831-836.
33. Yokoigawa, K., R. Hirasawa, H. Ueno, Y. Okubo, S. Umesako, and K. Soda. 2001. Gene cloning and characterization of alanine racemases from Shigella dysenteriae, Shigella boydii, Shigella flexneri, and Shigella sonnei. Biochem. Biophys. Res. Commun. 288:676-684.